Methods of treating diabetic cardiomyopathy using glycogen...

Details Methods of treating diabetic cardiomyopathy using glycogen... Methods of treating diabetic cardiomyopathy using glycogen...

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61K 31/00 (2006.01) A61K 31/404 (2006.01) A61K 31/407 (2006.01) A61K 31/427 (2006.01) A61K 31/443 (2006.01) A61K 31/454 (2006.01) A61K 31/496 (2006.01) A61K 31/5355 (2006.01) A61K 31/5377 (2006.01) A61K 31/695 (2006.01) A61K 45/06 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2331847

Disclosed are drugs for treating diabetic cardiomyopathy, comprising a glycogen phosphorylase inhibitor. Also provided are drugs for treating diabetic cardiomyopathy in a patient having 1) diabetes and 2) having cardiovascular disease, ischemic heart disease, congestive heart failure, congestive heart failure but not having coronary arteriosclerosis, hypertension, diastolic blood pressure abnormalities, microvascular diabetic complications, abnormal left ventricular function, myocardial fibrosis, abnormal cardiac function, pulmonary congestion, small vessel disease, small vessel disease without atherosclerotic cardiovascular disease or luminal narrowing, coagulopathy, cardiac contusion, or having had or at risk of having a myocardial infarction, the drugs comprising a glycogen phosphorylase inhibitor.

Affiliated with

Also associated with

Rating

Methods of treating diabetic cardiomyopathy using glycogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating diabetic cardiomyopathy using glycogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating diabetic cardiomyopathy using glycogen... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1980698